Biomarker may help identify prostate cancer patients at increased risk of metastasis

For about 90 percent of men with prostate cancer, the cancer remains localized to the primary site, resulting in a five-year survival rate of almost 100 percent.
Source: News Medical, https://www.news-medical.net/